Cure” is a not an immutable term, the authors of a new study write, and its meaning depends on the context in which it is ...

Children with spinal muscular atrophy (SMA) experience benefits from receiving a disease-modifying gene therapy, but many ...

Three different doses of Niktimvo all had high rates of response among patients with recurrent or refractory ...

The future of pain medicine is characterized by treatments and technologies — including virtual reality, AI, wearable tech ...

Merck and Johnson & Johnson have both acquired bispecific antibodies with applications in autoimmune and inflammatory conditions. Driving this growth will be the approvals of novel biologics, such as ...

Do you foresee IV and subQ route of administration always having a role moving forward? How do you see the treatment landscape changing?

Independence Blue Cross has increased local provider options by 47% since 2022, and now offers additional mental health and ...

When CMS begins negotiations for physician-administered drugs under the Inflation Reduction Act, providers, including those ...

Results of a survey show that Black/Indigenous/People of Color or Hispanic patients with Crohn's disease or ulcerative ...

Whether Express Scripts wins its unique defamation lawsuit will depend on whether the PBM can prove the FTC made false ...

More than half (60%) of patients in latest trial reached active remission and 41% stopped taking corticosteroid entirely.

The FDA has approved Lilly’s Ebglyss (lebrikizumab-lbkz) for the treatment of moderate to severe atopic dermatitis in adults ...